SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered...
Highly experienced biotech executive and board member will assist Kalaris in achieving its next phase of growthPALO ALTO, Calif., April...
Al Zeyoudi: "Hosting such major international events reflects the UAE's pivotal role as a global hub for investment and trade"1,250 speakers...
Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian...
First-of-its-Kind Research Aims to Fill the Gap in Women's Hormonal Health NEW YORK, April 3, 2025 /PRNewswire/ -- FLO Living...
TORONTO, April 3, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial...
CARY, N.C., April 3, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
De-Risking Target Validation with Data-Driven Genomic Insights ROME, April 3, 2025 /PRNewswire/ -- IRBM, an integrated Contract Research Organization (CRO)...
YOKNEAM ILLIT, Israel, April 3, 2025 /PRNewswire/ -- Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory...
BOSTON, April 3, 2025 /PRNewswire/ -- Lindus Health, the anti-CRO running radically faster, more reliable trials, has been awarded funding...
An INRS study based on natural selection is paving the way for very promising advances in biosurfactants. LAVAL, QC, April 3,...
Esteemed Life Sciences Leader Joins Board to Enhance Strategic Direction During Company Expansion Ben Daverman, Vantive Chief Strategy Officer Joins...
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on...
TAMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned...
FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
NDA Submission On-Target for Mid-2025KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing...
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to...
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to...
STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused...
-- Novel, locally administered gene therapy designed to boost cellular production of anti-inflammatory protein IL-1Ra in the knee -- --...